Pregnancy associates with alterations to the host and microbial proteome in vaginal mucosa
- PMID: 32196803
- PMCID: PMC7317380
- DOI: 10.1111/aji.13235
Pregnancy associates with alterations to the host and microbial proteome in vaginal mucosa
Abstract
Problem: Pregnant women are at increased risk of HIV acquisition, but the biological mechanisms contributing to this observation are not well understood.
Method of study: Here, we assessed host immune and microbiome differences in the vaginal mucosa of healthy pregnant and non-pregnant women using a metaproteomics approach. Cervicovaginal lavage (CVL) samples were collected from 23 pregnant and 25 non-pregnant women.
Results: Mass spectrometry analysis of CVL identified 550 human proteins and 376 bacterial proteins from 11 genera. Host proteome analysis indicated 56 human proteins (10%) were differentially abundant (P < .05) between pregnant and non-pregnant women, including proteins involved in angiogenesis (P = 3.36E-3), cell movement of phagocytes (P = 1.34E-6), and permeability of blood vessels (P = 1.27E-4). The major bacterial genera identified were Lactobacillus, Gardnerella, Prevotella, Megasphaera, and Atopobium. Pregnant women had higher levels of Lactobacillus species (P = .017) compared with non-pregnant women. Functional pathway analysis indicated that pregnancy associated with changes to bacterial metabolic pathway involved in energy metabolism, which were increased in pregnant women (P = .035).
Conclusion: Overall, pregnant women showed differences in the cervicovaginal proteome and microbiome that may be important for HIV infection risk.
Keywords: HIV; microbiome; pregnancy; proteomics.
© 2020 The Authors. American Journal of Reproductive Immunology published by John Wiley & Sons Ltd.
Figures
References
-
- Taha TE, Dallabetta GA, Hoover DR, et al. Trends of HIV‐1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi. AIDS. 1998;12(2):197‐203. - PubMed
-
- Leroy V, Van de Perre P, Lepage P, et al. Seroincidence of HIV‐1 infection in African women of reproductive age: a prospective cohort study in Kigali, Rwanda, 1988–1992. AIDS. 1994;8(7):983‐986. - PubMed
-
- Mbizvo MT, Kasule J, Mahomed K, Nathoo K. HIV‐1 seroconversion incidence following pregnancy and delivery among women seronegative at recruitment in Harare, Zimbabwe. Cent Afr J Med. 2001;47(5):115‐118. - PubMed
-
- Moodley D, Esterhuizen TM, Pather T, Chetty V, Ngaleka L. High HIV incidence during pregnancy: compelling reason for repeat HIV testing. AIDS. 2009;23(10):1255‐1259. - PubMed
